Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
BMC Med Educ ; 19(1): 364, 2019 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-31547807

RESUMEN

BACKGROUND: Mentoring plays a pivotal role in workplace-based learning, especially in the medical realm. Organising a formal mentoring programme can be labor and time intensive and generally impractical in resource constrained medical schools with limited numbers of mentors. Hence, informal mentoring offers a valuable alternative, but will be more likely to be effective when mentors and protégés share similar views. It is therefore important to gain more insight into factors influencing perceptions of informal mentoring. This study aims to explore mentors and protégés' perceptions of informal mentoring and how these vary (or not) with gender, age and the duration of the relationship. METHOD: We administered an Informal Mentor Role Instrument (IMRI) to medical practitioners and academics from Egypt, Pakistan and Saudi Arabia. The questionnaire was developed for the study from other validated instruments. It contained 39 items grouped into 7 domains: acceptance, counselling, friendship, parenting, psychological support, role modelling and sociability. RESULTS: A total of 103 mentors and 91 protégés completed the IMRI. Mentors had a better appreciation for the interpersonal aspects of informal mentoring than protégés, especially regarding acceptance, counselling and friendship. Moreover, being older and engaged in a longer mentoring relationship contributed to more positive perceptions of interpersonal aspects of mentoring, regardless of one's role (mentor or protégé). CONCLUSION: It can be concluded that the expectations of mentors and protégés differed regarding the content and aim of the interpersonal characteristics of their mentoring relationship. We recommend mentors and protégés to more explicitly exchange their expectations of the informal mentoring relationship, as typically practiced in formal mentoring. Additionally, in our study, seniority and lasting relationships seem crucial for good informal mentoring. It appears beneficial to foster lasting informal mentoring relationships and to give more guidance to younger mentors.


Asunto(s)
Mentores , Médicos/psicología , Lugar de Trabajo/psicología , Femenino , Humanos , Relaciones Interpersonales , Masculino , Tutoría , Mentores/psicología , Satisfacción Personal , Factores de Tiempo
2.
Int J Infect Dis ; 92: 13-18, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31863879

RESUMEN

OBJECTIVES: Egypt ranks first regarding the prevalence of hepatitis C virus (HCV) infection. Many patients have concomitant diseases like kidney disorders requiring hemodialysis, a procedure carrying the hazard of transmitting other hepatitis viruses. The purpose of this study was to investigate for occult hepatitis B virus (HBV), SEN virus (SENV), and torque teno virus (TTV) among chronic HCV patients on maintenance hemodialysis to identify their impacts. METHODS: A total of 325 hemodialysis patients were enrolled and divided into two groups based on HCV RNA testing results. Blood samples were collected before hemodialysis. Sera were tested for hepatitis B core antibodies (anti-HBc) and hepatitis B surface antibodies (anti-HBs) using ELISA. HBV, SENV, and TTV DNA were detected by PCR. The serum alanine aminotransferase (ALT) level was measured. RESULTS: Anti-HBc and HBV DNA were detected in 73.1% and 50.8% of group 1 versus 36.4% and 22.6% of group 2. The serum ALT level was higher in group 1 than group 2. SENV was detected in 11.5% of group 1 versus 8.2% of group 2. TTV was detected in 29% of group 1 versus 27% of group 2. CONCLUSIONS: There is an increased prevalence of occult HBV in our locality among chronic HCV patients undergoing hemodialysis. The existence of SENV and TTV viremia has no clinical impact.


Asunto(s)
Virus de la Hepatitis B , Hepatitis C Crónica/virología , Diálisis Renal , Torque teno virus , Adulto , Alanina Transaminasa/sangre , Egipto , Ensayo de Inmunoadsorción Enzimática , Femenino , Hepacivirus , Anticuerpos contra la Hepatitis B/sangre , Virus de la Hepatitis B/aislamiento & purificación , Hepatitis C Crónica/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Prevalencia , Torque teno virus/aislamiento & purificación
3.
J Med Microbiol ; 52(Pt 4): 331-335, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12676872

RESUMEN

Rapid, sensitive and low-cost methods are needed urgently for the detection of Mycobacterium tuberculosis in clinical samples, especially in developing countries. To this end, the clinical performance of FASTPlaqueTB(TM) (a bacteriophage-based method) has been studied in parallel with microscopy, standard microbiological culture and in-house IS6110-based PCR methods. A total of 64 samples, including 42 sputum samples and 22 urine samples, were tested in this study. The sensitivity, specificity and overall accuracy values for the FASTPlaqueTB assay relative to that of culture were respectively 76.5, 95 and 90 %. The corresponding values for the in-house IS6110-based PCR assay were 88, 91 and 90 % and, for Ziehl-Neelsen staining, were 59, 95 and 85 %. FASTPlaqueTB gave better clinical performance with urine samples than with sputum samples (sensitivity, specificity and overall accuracy were 100 % with urine samples and 64, 93 and 84 % with sputum samples). The 100 % sensitivity of FASTPlaqueTB was higher than that of the corresponding values for PCR (67 %) with urine samples. In conclusion, FASTPlaqueTB proved to be sensitive, cheap relative to the PCR and rapid. It is able to detect M. tuberculosis in clinical samples within 1 day, reducing the time to diagnosis in comparison with culture.


Asunto(s)
Micobacteriófagos/aislamiento & purificación , Mycobacterium tuberculosis/aislamiento & purificación , Tuberculosis/diagnóstico , Bacteriuria/microbiología , ADN Bacteriano/aislamiento & purificación , Humanos , Micobacteriófagos/crecimiento & desarrollo , Micobacteriófagos/fisiología , Mycobacterium tuberculosis/genética , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Esputo/microbiología , Coloración y Etiquetado , Tuberculosis/microbiología , Ensayo de Placa Viral
4.
J Infect Dev Ctries ; 7(11): 859-67, 2013 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-24240045

RESUMEN

INTRODUCTION: Hepatitis C virus (HCV) infections remain an increasingly prevalent and emergent health problem worldwide, causing a wide spectrum of liver diseases. Combination therapy with pegylated interferon (PEG-IFN) of peginterferon alfa-2a and oral ribavirin is currently recognized as the standard treatment of chronic HCV infection. Several complex immunological mechanisms are involved during the course of HCV treatment using interferons. The role of endogenous interferon gamma (IFNγ) in Egyptian patients infected with chronic HCV and treated with PEG-IFN/ribavirin is uncertain. The goal of this study was to evaluate the association of IFNγ and chronic HCV infection among patients treated with combination therapy of PEG-IFN/ribavirin. METHODOLOGY: Samples from 20 patients infected with HCV genotype-4 (HCV-4) and 20 non-infected individuals as healthy controls were used in this retrospective study. IFNγ levels in peripheral blood monocytes were analyzed, along with liver enzyme alanine aminotransferase (ALT) levels, and single nucleotide polymorphism (SNP) of the myxovirus resistance-A (MxA) gene. RESULTS: The results showed that an increase of IFNγ and a decrease of ALT levels in chronic HCV-infected patients after 12 weeks of treatment with combination therapy. CONCLUSION: Enhanced IFNγ secretion and decreased liver enzyme ALT production are indicative of HCV clearance and improvement of liver function. In addition, the SNP of the MxA gene is an important host genetic factor that independently influenced the response to IFNα in patients with chronic HCV infection, especially in those with a low viral load.


Asunto(s)
Antivirales/uso terapéutico , Hepatitis C Crónica/tratamiento farmacológico , Hepatitis C Crónica/inmunología , Interferón-alfa/uso terapéutico , Interferón gamma/metabolismo , Polietilenglicoles/uso terapéutico , Ribavirina/uso terapéutico , Alanina Transaminasa/sangre , Egipto , Genotipo , Hepacivirus/clasificación , Hepacivirus/genética , Hepacivirus/aislamiento & purificación , Hepatitis C Crónica/virología , Humanos , Leucocitos Mononucleares/inmunología , Proteínas de Resistencia a Mixovirus/genética , Polimorfismo de Nucleótido Simple , Proteínas Recombinantes/uso terapéutico , Estudios Retrospectivos
6.
Egypt J Immunol ; 14(2): 73-82, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-20306659

RESUMEN

Eotaxin is a chemokine with a selective eosinophil chemoattraction and its receptor is the chemokine receptor CCR3. The presence of CCR3 on Th2 lymphocytes is of particular interest. This work was performed to evaluate circulating level of chemokine eotaxin and CCR3 expression in allergic patients. It included 60 patients [23 (38.3%) with asthma, 20 (33.4%) with allergic rhinitis and 17 (28.3%) with skin allergy] and 12 controls. The level of plasma eotaxin & CCR3 expression on CD4+ T cells were determined by ELISA & flowcytometry respectively. Both plasma eotaxin level and expression of CCR3 on CD4+ T cells were higher in allergic patients than controls in different types of allergy. In conclusion, plasma eotaxin concentration is a candidate biological marker for the evaluation of allergic diseases.


Asunto(s)
Linfocitos T CD4-Positivos/metabolismo , Quimiocina CCL11/sangre , Hipersensibilidad/diagnóstico , Receptores CCR3/biosíntesis , Adolescente , Adulto , Anciano , Asma/sangre , Asma/diagnóstico , Asma/metabolismo , Biomarcadores/sangre , Biomarcadores/metabolismo , Niño , Dermatitis Atópica/sangre , Dermatitis Atópica/diagnóstico , Dermatitis Atópica/metabolismo , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Humanos , Hipersensibilidad/sangre , Hipersensibilidad/metabolismo , Masculino , Persona de Mediana Edad , Rinitis/sangre , Rinitis/diagnóstico , Rinitis/metabolismo , Pruebas Cutáneas , Adulto Joven
7.
Egypt J Immunol ; 12(1): 65-76, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16734141

RESUMEN

We investigated 120 patients suspected clinically to have pulmonary aspergillosis with different clinical manifestations "aspergilloma (Subgroup A), allergic bronchopulmonary aspergillosis (Subgroup B) and invasive pulmonary aspergillosis (Subgroup C)" and correlated between their clinical and laboratory findings and endogenous specific aflatoxin production. They were subjected to isolation of Aspergillus strains, measurement of serum total IgE and specific Aspergillus IgG by ELISA and identification of aflatoxin producing Aspergillus strains using fluorescence analysis of spectroline. Aspergillus was isolated from 45 patients (37.5%). Subgroup A had a negative statistically non-significant correlation between clinical and laboratory findings as regard total IgE and for Aspergillus IgG (only haemoptysis &weight loss had significant correlation with aspergillus IgG). Subgroup B & Subgroup C had positive, statistically significant correlation &negative statistically non significant correlation respectively as regard all clinical findings and both total IgE & serum IgG. This study also showed that 6 Aspergillus strains out of 45(13.3%) produced endogenous aflatoxin. It is concluded that a significant correlation that exists between clinical and serological findings in allergic pulmonary aspergillosis. Aflatoxins may be produced in vivo by strains of Aspergillus and may result in manifestations similar to those caused by ingestion of aflatoxin in food.


Asunto(s)
Aspergilosis/inmunología , Aspergilosis/fisiopatología , Enfermedades Pulmonares/inmunología , Enfermedades Pulmonares/fisiopatología , Adolescente , Adulto , Aflatoxinas/biosíntesis , Anciano , Aspergilosis/metabolismo , Femenino , Humanos , Enfermedades Pulmonares/metabolismo , Enfermedades Pulmonares/microbiología , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda